Impact of Semaglutide on Body Composition in Adults with Overweight or Obesity: Exploratory Analysis of the STEP 1 Study

Rhodri King1; John P.H. Wilding2; Rachel L. Batterham3; Salvatore Calanna4; Luc F. Van Gaal5; Barbara M. McGowan6; Julio Rosenstock7; Marie T.D. Tran4; Sean Wharton8; Koutaro Yokote9; Niels Zeuthen4; Robert F. Kushner10

1 Somerset Weight Management Service, Musgrove Park Hospital, Taunton, UK
2 Obesity and Endocrinology Research, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK
3 University College London Centre for Obesity Research, University College London and National Institute of Health Research, UCLH Biomedical Research Centre and Centre for Weight Management and Metabolic Surgery, UCLH, London, UK
4 Novo Nordisk A/S, Søborg, Denmark;
5 Antwerp University Hospital, University of Antwerp, Edegem, Belgium
6 Guy’s and St Thomas’ NHS Foundation Trust, London, UK
7 Dallas Diabetes Research Center at Medical City, Dallas, TX, USA
8 The Wharton Medical Clinic, Toronto, ON, Canada
9 Graduate School of Medicine, Chiba University and Chiba University Hospital, Chiba, Japan
10 Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. 

Discipline: 
Diabetes
Clinical taxonomy: 
Obesity
Treatments for diabetes
Type 2 diabetes mellitus
Resource taxonomy: 
Posters

ABCD Webinar Series

ABCD Webinars